Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Abbvie inc. crawled time : 08:00 save search
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.09%
H: 0.39%
C: -0.36%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.43%
H: 0.67%
C: 0.21%
BAX | $39.65 0.33% 0.0% 2.3M
|
Health Technology
|
| O: 0.21%
H: 0.24%
C: -1.04%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BMRN S | $90.08 -0.43% -0.43% 940K
|
Health Technology
|
| O: -0.38%
H: 1.79%
C: 0.22%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.4%
H: 0.19%
C: -0.33%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
america therapeutics growth market
Allergan Aesthetics Showcases Commitment to Individuality, Innovation, and Integrity at IMCAS World Congress 2024
Published: 2024-01-25 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
congress world
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio
Published: 2023-10-04 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.69%
H: 0.8%
C: 0.8%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 17.72%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -3.27%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.81%
H: 0.19%
C: -0.28%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
antibacterial asia market
Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published: 2023-09-26 (Crawled : 08:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -3.05%
H: 1.75%
C: 0.5%
SYK | $327.45 -2.55% 0.0% 2.1M
|
Health Technology
|
| O: -0.92%
H: 0.24%
C: -3.93%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.46%
C: -0.31%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.49%
H: 0.65%
C: -0.56%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.16%
H: 0.13%
C: -0.32%
VCEL | $43.86 -5.19% -5.47% 430K
|
Health Technology
|
| O: 0.38%
H: 1.7%
C: -1.85%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -0.02%
H: 1.37%
C: 1.21%
research market
Dry Eye Syndrome Drugs Market to grow by USD 2,159.21 million from 2022 to 2027; The growing geriatric population drives the market - Technavio
Published: 2023-08-09 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 2.96%
C: 0.99%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.14%
H: 0.8%
C: 0.43%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -1.71%
H: 0.0%
C: 0.0%
growing eye market
U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine
Published: 2023-04-18 (Crawled : 08:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.11%
H: 0.14%
C: -0.88%
qulipta fda migraine
Human papillomavirus (HPV) therapeutics market size to grow by USD 953.3 million between 2022 and 2027; Growth driven by advent of vaccines - Technavio
Published: 2023-04-11 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: -0.77%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -1.27%
AXTA | $31.81 0.09% 0.0% 1.5M
|
Process Industries
|
| O: 1.27%
H: 1.02%
C: 0.5%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.13%
H: 0.68%
C: -0.07%
therapeutics growth market
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Published: 2023-02-27 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.36%
H: 0.97%
C: 0.67%
rinvoq treatment disease abbvie chmp positive
Testosterone replacement therapy market: North America to account for 58% of market growth, Driven by initiatives to increase awareness about hypogonadism among the population - Technavio
Published: 2023-02-17 (Crawled : 08:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: 1.55%
H: 3.26%
C: 2.93%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -1.03%
H: 2.08%
C: 1.39%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.24%
H: 1.61%
C: 1.52%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.25%
H: 1.5%
C: 1.45%
america therapy market
Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio
Published: 2022-12-08 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 1.24%
H: 0.97%
C: 0.19%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -1.17%
H: 1.09%
C: 1.01%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.41%
H: 1.75%
C: 0.66%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.0%
H: 0.5%
C: 0.36%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.13%
H: 0.76%
C: 0.33%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.26%
H: 0.03%
C: -0.33%
lung therapeutics cancer growth market
AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress
Published: 2022-12-06 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
migraine
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Moderate to Severe Active Crohn's Disease
Published: 2022-11-23 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.1%
H: 0.62%
C: -0.35%
skyrizi treatment disease active approval
Tyrosine Kinase Inhibitors Market Size to Grow by USD 19.07 Bn, North America to Account for 38% of Market Growth - Technavio
Published: 2022-10-20 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 4.6%
H: 0.47%
C: 0.4%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -1.41%
H: 2.96%
C: 2.96%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.82%
H: 0.57%
C: -0.43%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.47%
H: 0.45%
C: 0.07%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.42%
H: 0.64%
C: -0.38%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.02%
H: 0.61%
C: -0.16%
PBYI | $4.98 -3.68% -3.82% 290K
|
Health Technology
|
| O: 0.93%
H: 2.07%
C: -0.92%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -1.54%
H: 2.07%
C: 1.27%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.26%
H: 0.61%
C: -0.04%
america growth market
Male Hypogonadism Market Size to Grow by USD 684.95 Mn, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published: 2022-09-19 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.29%
H: 0.15%
C: -0.68%
LPCN | $5.47 2.82% 2.74% 21K
|
Health Technology
|
| O: -1.23%
H: 3.57%
C: -0.54%
market
AbbVie Secures Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderate to Severe Crohn's Disease
Published: 2022-09-19 (Crawled : 08:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.29%
H: 0.15%
C: -0.68%
skyrizi treatment disease chmp risankizumab positive
AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients
Published: 2022-06-10 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -3.55%
H: 0.0%
C: 0.0%
The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Risankizumab (SKYRIZI®) in Crohn's Disease
Published: 2022-05-27 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
skyrizi disease lancet risankizumab results phase 3
The Lancet Publishes Results from Phase 3 Induction and Maintenance Programs Evaluating Upadacitinib (RINVOQ®) in Ulcerative Colitis
Published: 2022-05-27 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
rinvoq lancet results phase 3 ulcerative colitis
AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases
Published: 2022-03-11 (Crawled : 08:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
disease collaboration neuropsychiatric
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.